Since its inception in 2002, donations to the Ricky Fund have provided funding for several important research projects to investigate hypertrophic cardiomyopathy (HCM) in cats. With continued support from pet owners everywhere, Winn envisions a future where we can learn to prevent HCM whenever possible, and effectively treat those cats that are affected. For more information on HCM, see our HCM information and our FAQ for breeders. The projects funded to date include:

  • Anticoagulant effects of low molecular weight heparin in normal cats: University of Pennsylvania; 2003
  • Effect of ramipril on cardiac mass and fibrosis in feline familial hypertrophic cardiomyopathy: University of California, Davis; 2003
  • Molecular evaluation of the feline myosin binding protein C gene in Maine Coon cats with familiar hypertrophic cardiomyopathy: Ohio State University, University of California; 2004
  • Effect of pirfenidone on myocardial fibrosis and diastolic function in feline familial hypertrophic cardiomyopathy: University of California, Davis; 2005
  • Molecular evaluation of the feline myosin heavy chain gene in Ragdoll, Norwegian Forest and Sphynx cats with familial hypertrophic cardiomyopathy:Washington State University; 2007
  • Molecular evaluation of the feline myosin binding protein C gene in Siberian cats with familial hypertrophic cardiomyopathy: Washington State University; 2008
  • Molecular evaluation of the feline alpha tropomyosin gene in Norwegian Forest, Sphynx, Siberian, Ragdoll and Maine Coon cats with familial hypertrophic cardiomyopathy: Washington State University; 2008
Ricky Fund Projects
WINN FELINE
FOUNDATION